DuPont de Nemours Files 8-K
Ticker: DD · Form: 8-K · Filed: Oct 15, 2025 · CIK: 1666700
| Field | Detail |
|---|---|
| Company | Dupont De Nemours, Inc. (DD) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-filing
TL;DR
DuPont filed an 8-K on 10/15/25. Standard reporting.
AI Summary
DuPont de Nemours, Inc. filed an 8-K on October 15, 2025, reporting other events and financial statements. The filing is related to their operations as a plastics, materials, and resins company incorporated in Delaware.
Why It Matters
This filing indicates ongoing corporate reporting and potential updates on financial or operational matters for DuPont de Nemours, Inc.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate reporting and does not appear to contain significant new information or events.
Key Players & Entities
- DuPont de Nemours, Inc. (company) — Registrant
- October 15, 2025 (date) — Date of earliest event reported
- Delaware (location) — State of incorporation
- 001-38196 (other) — Commission file number
- 81-1224539 (other) — IRS Employer Identification No.
- 974 Centre Road, Building 730 Wilmington, Delaware 19805 (address) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of October 15, 2025.
When was the earliest event reported in this filing?
The earliest event reported is dated October 15, 2025.
In which state is DuPont de Nemours, Inc. incorporated?
DuPont de Nemours, Inc. is incorporated in Delaware.
What is the Commission file number for DuPont de Nemours, Inc.?
The Commission file number is 001-38196.
What is the business address of DuPont de Nemours, Inc.?
The business address is 974 Centre Road, Building 730, Wilmington, Delaware 19805.
Filing Stats: 1,197 words · 5 min read · ~4 pages · Grade level 12.8 · Accepted 2025-10-15 16:31:03
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share DD New York Stock Exchange
Filing Documents
- dd-20251015.htm (8-K) — 34KB
- exhibit991boardapprovalofq.htm (EX-99.1) — 29KB
- ddlogo.jpg (GRAPHIC) — 5KB
- qnitylogo.jpg (GRAPHIC) — 3KB
- 0001666700-25-000054.txt ( ) — 227KB
- dd-20251015.xsd (EX-101.SCH) — 2KB
- dd-20251015_def.xml (EX-101.DEF) — 15KB
- dd-20251015_lab.xml (EX-101.LAB) — 26KB
- dd-20251015_pre.xml (EX-101.PRE) — 15KB
- dd-20251015_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On October 15, 2025, the board of directors of DuPont de Nemours, Inc. (the "Company" or "DuPont") approved the previously announced tax-free separation (the "Separation") of the Company's Electronics business, Qnity Electronics, Inc. ("Qnity"). To effect the Separation, the board of directors of DuPont declared a pro rata dividend of all of the issued and outstanding shares of common stock, par value $0.01 per share, of Qnity (the "Qnity Common Stock") to the Company's stockholders (the "Distribution") as of the close of business on October 22, 2025 (the "Record Date"). The Distribution is expected to be paid on November 1, 2025. Effective as of the Distribution, each Company stockholder of record will receive one share of Qnity Common Stock for every two shares of the Company's common stock held by such stockholder as of the Record Date (such ratio, the "Distribution Ratio"). The Company will not distribute any fractional shares of Qnity Common Stock to its stockholders as part of the Distribution. Instead, the Company's stockholders will receive cash in lieu of any fractional shares of Qnity Common Stock that they would have received after application of the Distribution Ratio . Following the consummation of the Separation and the Distribution, the Company's stockholders will own 100% of the outstanding shares of Qnity Common Stock, and Qnity will become an independent, publicly traded company. The consummation of the Separation and the Distribution is subject to the satisfaction or waiver of certain conditions, as more fully described in the final information statement, dated as of October 15, 2025, attached as Exhibit 99.1 to Qnity's Current Report on Form 8-K filed by Qnity with the U.S. Securities and Exchange Commission on October 15, 2025 and not incorporated by reference herein, which DuPont expects will be satisfied by the Distribution. In addition, the New York Stock Exchange (the "NYSE") has authorized the Qnity Common St
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of DuPont de Nemours, Inc., dated October 15, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Cautionary Statement Regarding Forward Looking Statements This Current Report on Form 8-K contains forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "intend", "may", "could", "project", "estimate" and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to, the successful completion of the Separation and Distribution, including achievement of the intended tax treatment; the possibility of disputes, litigation or unanticipated costs in connection with the Separation and Distribution; and DuPont's success in achieving its intended post-Separation capital structure. Additional information concerning the risks, uncertainties and assumptions can be found in DuPont's filings with the U.S. Securities and Exchange Commission,
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DUPONT DE NEMOURS, INC. Registrant Date: October 15, 2025 By: /s/ Erik T. Hoover Name: Erik T. Hoover Title: Senior Vice President and General Counsel